Sunnyvale, CA, November 4, 2003-- Labcyte Inc. announced that its seventh U.S. patent 6,642,061 entitled “Use of Immiscible Fluids in Droplet Ejection Through Application of Focused Acoustic Energy” issued today. This technology has applications in the use of multiple layer droplets for miniaturized arrayed assays.
Labcyte Inc. is a privately held
company headquartered in Sunnyvale, California. The company provides a broad range of systems for liquid handling
and microwell plate processing as well as an extensive line of plastic
consumables for use on its own instruments and those from other
manufacturers. The 100 nanoliter to 300
microliter liquid transfer range is covered by a collection of instruments
known for their small footprint and ease of conversion among formats. For
transfers below 100 nanoliters, Labcyte is developing the acoustic droplet
ejection (ADE) with broad applications in the life science including dispensing
equipment, assay systems, particle manufacturing, microarrays, and living cell
transfer devices. The company’s initial
ADE-based product, the Echo 550, is a system for precisely transferring low
nanoliter volumes of potential drug compounds into assay plates. Picoliter has 7 issued U. S. patents and 30
applications pending with the USPTO as well as additional international
filings.
To lean more about Labcyte Inc.,
please visit our new website, www.labcyte.com.
Contact information:
Elaine J. Heron, Ph.D.
Chief Executive Officer
Labcyte Inc.
1190 Borregas Avenue
Sunnyvale, CA 94089
(408) 747-2000 x 108
(408) 747-2009 (FAX)
www.labcyte.com